The effect of transforming growth factor (TGF)-β1 and (TGF)-β2 on nasal polyp fibroblast activities involved upper airway remodeling: Modulation by fluticasone propionate

Immunology Letters

Volumn 105, Issue 1, 2006, Pages 61-67

  Serpero, Laura ^a   Petecchia, Loredana ^a   Sabatini, Federica ^a   Giuliani, Massimo ^a   Silvestri, Michela ^a   Di Blasi, Patrizia ^b   Rossi, Giovanni A ^a  

^a G GASLINI INSTITUTE   (Italy)

^b GSK   (Italy)

Author keywords

Fibroblasts; Nasal polyps; Transforming growth factor beta

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FLUTICASONE PROPIONATE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FIBROBLAST; HUMAN; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; MALE; MYOFIBROBLAST; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPPER RESPIRATORY TRACT;

ACTINS; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; FIBROBLASTS; HUMANS; MALE; NASAL POLYPS; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 33646362766     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.01.003     Document Type: Article

References (34)

1. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 6 (1990) 597-641
2. Roberts A.B., and Sporn M.B. The transforming growth factor-β. In: Sporn M.B., and Roberts A.B. (Eds). Handbook of experimental pharmacology: peptide growth factors and their receptors vol. 95 (1990), Springer-Verlag, New York 419-472
3. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med 342 (2000) 1350-1358
4. Bartram U., and Speer C.P. The role of transforming growth factor beta in lung development and disease. Chest 125 (2004) 754-765
5. Singer A.J., and Clark RA.F. Cutaneous wound healing. N Engl J Med 341 (1999) 738-746
6. Border W.A., and Noble N.A. Transforming growth factor β in tissue fibrosis. N Engl J Med 331 (1994) 1286-1292
7. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 3 (2003) 1-6
8. Watelet J.B., Claeys C., Perez-Novo C., Gevaert P., Van Cauwenberge P., and Bachert C. Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 18 (2004) 267-272
9. Steinke J.W., Crouse C.D., Bradley D., Hise K., Lynch K., Kountakis S.E., et al. Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 30 (2004) 212-219
10. Eisma R.J., Allen J.S., Lafreniere D., Leonard G., and Kreutzer D.L. Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: role of the cytokines in this disease process. Am J Otolaryngol 18 (1997) 405-411
11. Coste A., Lefaucheur J.P., Wang Q.P., Lesprit E., Poron F., Peynegre R., et al. Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 124 (1998) 1361-1366
12. Schürch W., Seemayer T.A., and Gabbiani G. Myofibroblast. In: Sternberg S.S. (Ed). The histology for pathologists (1992), Raven Press Ltd., New York 109-144
13. Wang Q.P., Escudier E., Roudot-Thoraval F., Abd-Al Samad I., Peynegre R., and Coste A. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 107 (1997) 926-931
14. Silvestri M., Oddera S., Crimi P., and Rossi G.A. Frequency and specific sensitization to inhalant allergens within nuclear families of children with asthma and/or rhinitis. Ann Allergy Asthma Immunol 79 (1997) 512-516
15. Silvestri M., Sabatini F., Scarso L., Cordone A., and Rossi G.A. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int Arch Immunol 128 (2002) 51-58
16. Brouty-Boyé D., Doucet C., Clay D., Le Bousse-Kerdilès M.-C., Lampidis T.J., and Azzarone B. Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues. Int J Cancer 76 (1998) 767-773
17. Sabatini F., Silvestri M., Sale R., Serpero L., Giuliani M., Scarso L., et al. Concentration-dependent effects of mometasone furoate and dexamethasone on foetal lung fibroblast functions involved in airway inflammation and remodeling. Pulm Pharmacol Ther 16 (2003) 287-297
18. Silvestri M., Fregonese L., Sabatini F., Dasic G., and Rossi G.A. Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur Respir J 18 (2001) 139-145
19. Muchaneta-Kubara E.C., and el Nahas A.M. Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 12 (1997) 904-915
20. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., and Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12 (2001) 2730-2741
21. Esmailpour N., Hogger P., Rabe K.F., Heitmann U., Nakashima M., and Rohdewald P. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 10 (1997) 1496-1499
22. Dolovich J., Ohtoshi T., Jordana M., Gauldie J., and Denburg J. Nasal polyps: local inductive microenvironment in the pathogenesis of the inflammation. In: Mygind N., and Pipkorn U. (Eds). Rhinitis and asthma (1990), Munksgard, Copenhagen 233-241
23. Norlander T., Westrin K.M., Fukami M., Stierna P., and Carlsoo B. Experimental induced polyps in the sinus mucosa: a structural analysis of the initial stage. Laryngoscope 106 (1996) 196-203
24. Tschumperlin D.J., Shively J.D., Kikuchi T., and Drazen J.M. Mechanical stress triggers selective release of fibrotic mediators from bronchial epithelium. Am J Respir Cell Mol Biol 28 (2003) 142-149
25. Levi-Schaffer F., Garbuzenko E., Rubin A., Reich R., Pickholz D., Gillery P., et al. Human eosinophils regulate human lung- and skin-derived fibroblast propierties in vitro: a role for transforming growth factor β (TGF-β). Pro Natl Acad Sci USA 96 (1999) 9660-9665
26. 3. J Immunol 151 (1993) 4534-4544
27. Lee M., Hwang C., Lee J., Slavkin H., and Warburton D. TGF-β isoforms differentially attenuate EGF mitogenicity and receptor activity in fetal lung mesenchymal cells. Am J Physiol 273 (1997) L374-L381
28. 1-dependent and independent mechanisms. J Invest Dermatol 108 (1997) 258-262
29. Kottler U.B., Junemann A.G., Aigner T., Zenkel M., Rummelt C., and Schlotzer-Schrehardt U. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp Eye Res 80 (2005) 121-134
30. Chang C.H., Chai C.Y., Ho K.Y., Kuo W.R., Tai C.F., Lin C.S., et al. Expression of transforming growth factor-beta 1 and alpha-smooth muscle actin of myofibroblast in the pathogenesis of nasal polyps. Kaohsiung J Med Sci 17 (2001) 133-138
31. Holmberg K., Julliusson S., Balder B., Smith D.L., Richards D.H., and Karlsson G. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 78 (1997) 270-276
32. Hamilos D.L., Tjawley S.T., Kramper M.A., Kamil A., and Hamid Q.A. Effects of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol 103 (1999) 79-87
33. Barnes P.J., and Adcock I.M. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14 (1993) 436-441
34. Badia L., and Lund V. Topical corticosteroids in nasal polyposis. Drugs 61 (2001) 573-578